In spite of several clinical differences, COVID19 and COPD patients may present similar clinical outcome, such as acute exacerbations, resulting in exaggerated inflammatory response and increased NRL and IL6 levels (Chen et al., 2016; Wang et al., 2020). Here, NRL is linked to COVID-19.